TRENDING

• Case Study #3 – Evan Williams, serially successful internet entrepreneur He coined the term “blogger” and successfully built 3 digital publishing (blog based) businesses. under Blog
• Company Profile: LiveTiles (ASX:LVT) Why LiveTiles (ASX:LVT) could be the next billion dollar ASX SaaS company. under Company Profiles
• Case Study #2 – Rod Drury, successful serial software entrepreneur Rod saw the potential of the ‘cloud computing’ before Google. under Blog
• Entrepreneurs who built successful USD1bn geospatial technology company, join new geospatial software venture In 2016, Pointerra's founding Chairman and Non-Executive Director saw an opportunity to build another USD1bn technology company in the geospatial sector. under Public, Technology
• Company Profile: Botanix Pharmaceuticals (ASX : BOT) This article is a detailed break-down of Botanix Pharmaceuticals (“Botanix”), which listed on the Australian Stock Exchange (ASX) in 2015 under the ticker BOT. under Company Profiles
• Company Profile: intelliHR (ASX:IHR) I believe intelliHR’s SaaS based operational metrics put it in the 75th percentile when compared to global SaaS companies at its current stage (e.g. Sales and Marketing efficiency (Magic Number), Gross Profit Margin (GPM) and Annual Recurring Revenue (ARR) growth), NPS). under Company Profiles
• Entrepreneurs who sold their successful IT business for AUD25m, start IT software venture on the ASX Kyle Redenbach and Peter Nguyen-Brown were the Co-founders of nSynergy Group. It was acquired by Rhipe Limited (ASX:RHP) for AUD25m in 2014. under Public, Technology
• Successful biotechnology entrepreneur with a AUD60m exit, starts next biotechnology venture Matthew Callahan was the Founder and CEO of iCeutica, which was acquired by Iroko Pharmaceuticals for AUD60m in 2011. under Healthcare, Public
• Company Profile: Pointerra (ASX:3DP) Pointerra is a company that Track Record News reported on 1 April 2020 called “entrepreneurs who built a successful USD1bn geospatial technology company, join a new geospatial software venture.” under Company Profiles
• Company Profile: K2fly (ASX:K2F) Its Annual Recurring Revenue (ARR) has grown from approximately AUD850k to AUD2.36m in the last 12 months (177% Year on Year (YoY) growth) as at 30 June 2020. The company has achieved this growth while achieving cash flow break-even last quarter and maintaining AUD3m in the bank. under Company Profiles
• Billionaire tech entrepreneur, Bevan Slattery, invests AUD2.5m in ASX SaaS startup Billionaire tech entrepreneur, Bevan Slattery, invests AUD2.5m in ASX SaaS startup under Public, Technology
• How you could have made 100x your money investing in this micro cap SaaS company By simply following this successful industry entrepreneur's investment in this publicly listed small cap, investors made more than a 100x return on their investment. under Blog
• Case Study #4 – Matthew Callahan, successful serial biotechnology entrepreneur This successful entrepreneur is responsible for 4 Food Delivery Association (FDA) product approvals in the dermatology industry. under Blog
• Why successful entrepreneurs makes investors more money, more often On average, successful entrepreneurs are 9.70% and 8% more likely to be successful compared to first time entrepreneurs and failed entrepreneurs, respectively. under Blog
• 5 x successful mining entrepreneur with a CDN4.3bn exit, starts new mining venture Robert Friedland was the Co-founder and Co-chairman of Diamond Fields Resources, which was acquired for CDN4.3bn. under Mining, Public
• Successful entrepreneurs are 48% more likely to succeed A successful entrepreneur is 48% more likely to succeed again. This means successful entrepreneurs makes investors money, more often. under Blog
• Successful entrepreneurs build businesses with larger revenues Larger revenues means larger valuations, which results in larger returns for investors. So by investing in successful entrepreneurs, investors can make more money, more often. under Blog
• Track Record’s Track Record #1 | 206% average share price increase for profiled companies, outperforms ASX All Ords by 175% Since 1 April 2020, Track Record has profiled 5 companies, which, on average, their share price has risen by 206%. The top 2 companies were Pointerra (ASX:3DP) at 2,150% (21x) and Botanix Pharmaceuticals at 200% (2x) as at 14 December 2020. This means the profiled companies outperformed the ASX All Ords by 175% since 1 ... under Blog